The preoperative identification of diffuse gliomas holds substantial clinical value, given that gross total resection significantly enhances prognosis in “astrocytoma, IDH-mutant” compared to other entities [8, 9]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).